Format

Send to

Choose Destination
CA Cancer J Clin. 2017 Jan;67(1):31-50. doi: 10.3322/caac.21386. Epub 2016 Nov 29.

An update on larynx cancer.

Author information

1
Assistant Professor, Department of Hematology Oncology, Winship Cancer Institute of Emory University, Atlanta, GA.
2
Associate Professor, Department of Otolaryngology, Winship Cancer Institute of Emory University, Atlanta, GA.
3
Resident, Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, GA.
4
Assistant Professor, Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, GA.
5
Professor and Director of the Head and Neck Medical Oncology Program, Department of Hematology Oncology, Winship Cancer Institute of Emory University, Atlanta, GA.

Abstract

Answer questions and earn CME/CNE Laryngeal cancer remains one of the most common tumors of the respiratory tract. Fortunately, significant advancements have been made over the past decade in the treatment of laryngeal cancer. Although surgery has been the historical mainstay for localized disease and still is an integral part of treatment, nonsurgical options like radiation and systemic therapy have emerged as viable options. In addition, in the metastatic setting, novel agents are showing promise for this patient population. The care for patients with laryngeal cancer continues to evolve and truly requires a multidisciplinary team-based approach. Unique morbidities, such as loss of natural voice, respiration, and airway protection during swallowing, are observed with this disease and require special consideration. CA Cancer J Clin 2017;67:31-50.

KEYWORDS:

cancer; laryngeal preservation; larynx; multimodality; squamous cell carcinoma

PMID:
27898173
DOI:
10.3322/caac.21386
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center